Bicara Therapeutics

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Intel, Cleanspark, Super Micro Computer, Upstart, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

movers image

BELFB

BIOA

HTBK

PSBD

RIOT

ZIMV

BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Wells Fargo ATM

Upgrades

Analyst Ratings

AFRM

FXNC

SAVA

UFPI

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Bicara Therapeutics Inc

IPOs

Press Releases

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

Earnings

Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Health Care

General

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01, a Pivotal Phase 2/3 Clinical Trial of Ficerafusp Alfa in 1L Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cogent Biosciences

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Gyre Therapeutics

Immunome

Kura Oncology

LENZ Therapeutics

Myriad Genetics

Opthea Limited - American Depositary Shares

Opthea

Organogenesis Hldgs

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

Relay Therapeutics

Sana Biotechnology

Sionna Therapeutics

Tyra Biosciences

Zymeworks

Wedbush

HC Wainwright & Co.

Stifel

Morgan Stanley

Comments

Bicara Therapeutics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga